Correction

This article refers to:

ENHANZE® drug delivery technology: a novel approach to subcutaneous administration using recombinant human hyaluronidase PH20

Article title: ENHANZE^® drug delivery technology: a novel approach to subcutaneous administration using recombinant human hyaluronidase PH20

Authors: Locke, K. W., Maneval, D. C., & LaBarre, M. J.

Journal: Drug Delivery

DOI: http://dx.doi.org/10.1080/10717544.2018.1551442

The article title has been changed from “ENHANZE^® drug delivery technology: a novel approach to subcutaneous administration using recombinant human hyaluronidase 20” to “ENHANZE^® drug delivery technology: a novel approach to subcutaneous administration using recombinant human hyaluronidase PH20”